Drug
Imetelstat KG
Imetelstat KG: highest development phase Phase 2, developed by Geron Corporation. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Geron Corporation
Trials
| Drug | Phase | Indication |
|---|---|---|
| Imetelstat 4.7 mg/kg NCT02426086 | Phase 2 | Myelofibrosis |
Latest
No recent events.
Follow Imetelstat KG on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.